MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.modpat.2023.100152

Медицинская библиотека · Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2023

Molecular Correlates of Aggressive Behavior and Biological Progression in Testicular Sertoli Cell Tumors.

Rizzo Natalie M, Sholl Lynette M, Kao Chia-Sui, Cornejo Kristine M, Sangoi Ankur R, Hirsch Michelle S, Collins Katrina, Gordetsky Jennifer B, Reyes Curcio Fabiola A, Fletcher Christopher D M, Ulbright Thomas M, Acosta Andres M

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Sertoli cell tumor (SCT) is the second most common type of sex cord-stromal tumor in men, and ∼10% exhibit malignant behavior. Although CTNNB1 variants have been described in SCTs, only a limited number of metastatic cases have been analyzed, and the molecular alterations associated with aggressive behavior remain largely unexplored. This study evaluated a series of nonmetastasizing and metastasizing SCTs using next-generation DNA sequencing to further characterize their genomic landscape. Twenty-two tumors from 21 patients were analyzed. Cases were divided into metastasizing SCTs and nonmetastasizing SCTs. Nonmetastasizing tumors were considered to have aggressive histopathologic features if they exhibited ≥1 of the following: size >2.4 cm, necrosis, lymphovascular invasion, ≥3 mitoses per 10 high-power fields, severe nuclear atypia, or invasive growth. Six patients had metastasizing SCTs, and the remaining 15 patients had nonmetastasizing SCTs; 5 nonmetastasizing tumors had ≥1 aggressive histopathologic feature(s). Gain-of-function CTNNB1 or inactivating APC variants were highly recurrent in nonmetastasizing SCTs (combined frequency >90%), with arm-level/chromosome-level copy number variants, loss of 1p, and CTNNB1 loss of heterozygosity occurring exclusively in CTNNB1-mutant tumors with aggressive histopathologic features or size >1.5 cm. Nonmetastasizing SCTs were almost invariably driven by WNT pathway activation. In contrast, only 50% of metastasizing SCTs harbored gain-of-function CTNNB1 variants. The remaining 50% of metastasizing SCTs were CTNNB1-wild-type and harbored alterations in the TP53, MDM2, CDKN2A/CDKN2B, and TERT pathways. These findings suggest that ∼50% of aggressive SCTs represent progression of CTNNB1-mutant benign SCTs, whereas the remaining ones are CTNNB1-wild-type neoplasms that exhibit alterations in genes of the TP53, cell cycle regulation, and telomere maintenance pathways.

Для цитирования: Rizzo Natalie M, Sholl Lynette M, Kao Chia-Sui, Cornejo Kristine M, Sangoi Ankur R, Hirsch Michelle S, Collins Katrina, Gordetsky Jennifer B, Reyes Curcio Fabiola A, Fletcher Christopher D M, Ulbright Thomas M, Acosta Andres M. Molecular Correlates of Aggressive Behavior and Biological Progression in Testicular Sertoli Cell Tumors.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2023. DOI: 10.1016/j.modpat.2023.100152.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.